"Mice, Transgenic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
| Descriptor ID |
D008822
|
| MeSH Number(s) |
B01.050.050.136.500 B01.050.150.900.649.313.992.635.505.500.800
|
| Concept/Terms |
Mice, Transgenic- Mice, Transgenic
- Mouse, Transgenic
- Transgenic Mouse
- Transgenic Mice
Founder Mice, Transgenic- Founder Mice, Transgenic
- Mice, Transgenic Founder
- Transgenic Founder Mice
- Mouse, Founder, Transgenic
|
Below are MeSH descriptors whose meaning is more general than "Mice, Transgenic".
Below are MeSH descriptors whose meaning is more specific than "Mice, Transgenic".
This graph shows the total number of publications written about "Mice, Transgenic" by people in this website by year, and whether "Mice, Transgenic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 9 | 9 |
| 2003 | 0 | 5 | 5 |
| 2004 | 0 | 4 | 4 |
| 2005 | 0 | 5 | 5 |
| 2006 | 1 | 18 | 19 |
| 2007 | 0 | 12 | 12 |
| 2008 | 0 | 18 | 18 |
| 2009 | 0 | 19 | 19 |
| 2010 | 0 | 22 | 22 |
| 2011 | 0 | 17 | 17 |
| 2012 | 0 | 19 | 19 |
| 2013 | 0 | 24 | 24 |
| 2014 | 0 | 22 | 22 |
| 2015 | 0 | 17 | 17 |
| 2016 | 1 | 18 | 19 |
| 2017 | 0 | 21 | 21 |
| 2018 | 0 | 10 | 10 |
| 2019 | 0 | 10 | 10 |
| 2020 | 0 | 18 | 18 |
| 2021 | 0 | 15 | 15 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mice, Transgenic" by people in Profiles.
-
Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy. Nat Commun. 2023 Apr 25; 14(1):2367.
-
Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism. Mol Cancer Res. 2022 09 02; 20(9):1391-1404.
-
Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling. Sci Rep. 2022 01 31; 12(1):1659.
-
Skeletal stem cell fate defects caused by Pdgfrb activating mutation. Development. 2021 12 01; 148(23).
-
Hippocampal gamma and sharp-wave ripple oscillations are altered in a Cntnap2 mouse model of autism spectrum disorder. Cell Rep. 2021 11 09; 37(6):109970.
-
Distal Lck Promoter-Driven Cre Shows Cell Type-Specific Function in Innate-like T Cells. Immunohorizons. 2021 09 28; 5(9):772-781.
-
Persistent Metabolic Effects of Tamoxifen: Considerations for an Experimental Tool and Clinical Breast Cancer Treatment. Endocrinology. 2021 09 01; 162(9).
-
Type 2 innate lymphoid cells from Id1 transgenic mice alleviate skin manifestations of graft-versus-host disease. BMC Immunol. 2021 07 13; 22(1):46.
-
Early manifestation of gait alterations in the Tg2576 mouse model of Alzheimer's disease. Geroscience. 2021 08; 43(4):1947-1957.
-
Naproxen inhibits spontaneous lung adenocarcinoma formation in KrasG12V mice. Neoplasia. 2021 06; 23(6):574-583.